Diabetes Outreach Network
QUICK REFERENCE GUIDE TO DIABETES FOR HEALTH CARE PROVIDERS

A special project of the Michigan Diabetes Outreach Network
 
Return to Table of Contents

Chapter 19
Chronic Complications of Diabetes

Chronic complications of diabetes include cardiovascular disease, neuropathy, nephropathy, retinopathy, periodontal disease, as well as complications from flu and pneumonia.

Research Studies
Striving for optimal glycemic control is the cornerstone in the prevention of diabetes complications. The Diabetes Control and Complications Trial (DCCT) compared intensive vs. conventional control in persons with type 1 diabetes. Intensive diabetes care reduced the risk of:

  • Retinopathy 76%
  • Neuropathy 60%
  • Nephropathy 50% and
  • Cardiovascular disease 35%.

Most participants were then enrolled in the Epidemiology of Diabetes Interventions and Complications (EDIC), an 8 year observation study. It showed further risk reduction in:

  • Heart and blood vessel disease by 42%
  • Heart attack, stroke, or heart and blood vessel disease-related death by 57%.

Similarly, the United Kingdom Prospective Diabetes Study (UKPDS) showed that improved blood glucose control in those with type 2 diabetes reduced risk of:

  • Retinopathy by 21%
  • Nephropathy by 33%.

The UKPDS also showed that improved blood pressure control reduced incidence of stroke and microvascular complications.

However, in light of recommended treatment goals, only:

  • 37% of adults with diagnosed diabetes achieved an A1C of <7%
  • 36% had a blood pressure <130/80 mmHg
  • 48% had a cholesterol <200 mg/dl
  • 7.3% met all three above goals.

Cardiovascular Disease (CVD), the number one killer in those with diabetes, includes coronary artery disease, myocardial infarction, peripheral vascular disease and cerebral vascular disease. Risk factors for CVD include duration of diabetes, age, genetics, race and gender, along with modifiable risk factors listed in the table below.

Guidelines for Reducing Risk of CVD

 
  Goal
Blood Pressure

Check at every medical visit
.. Optimal: < 120/80 mmHg
.. Minimal goal: < 130/80 mmHg
Take medications as prescribed

Cigarette Smoking

Advise not to smoke
Smoking cessation counseling for those who smoke

Diabetes

Strive for near normal blood glucose levels
Monitor blood glucose levels regularly
Take medications as prescribed

Diet

Limit saturated fats to <7% of total calories
Limit dietary cholesterol to < 200 mg
Limit intake of trans fatty acids
DASH Diet (See chapter 13 Hypertension and Diabetes)

Lipids

Check lipid profile at least once a year
.. LDL cholesterol < 100 mg/dl
.. HDL cholesterol > 40 mg/dl (men); > 50 mg/dl (women)
.. Triglycerides < 150 mg/dl
.. Non-HDL cholesterol* < 130 mg/dl
Take medications as prescribed

Physical Activity

30 minutes of moderate-intensity activity on most (preferably all) days of the week

Weight management

BMI of 18.5-24.9
Waist circumference: < 35“ (women); < 40“ (men)

Antiplatlet agents

Consider low dose aspirin in those over age 40
Consider other antiplatlet agent if contraindication to aspirin

 

* Current NCEP/ATP III guidelines suggest that "non-HDL cholesterol" (total cholesterol minus HDL) be utilized in those with triglycerides 200 mg/dl.

Lower Extremity Complications and Neuropathies
Diabetic neuropathy involves acute nerve abnormalities, followed by more chronic nerve damage, atrophy and loss. Up to 70% of persons with diabetes have nerve damage, which can lead to lower limb amputation. Common foot problems associated with diabetes include circulation, structural and neuropathic issues.

An annual comprehensive foot exam including a 5.07 monofilament test is recommended to screen for neuropathy. Suggested sites for monofilament testing are shown below.

   
   
 
 

    Persons with diabetes should be taught to examine their feet daily and report changes to their health care provider, including redness, swelling, ulcers, temperature change or structural changes. Reducing risk for lower extremity complications includes smoking cessation, controlling blood lipids, blood pressure and blood glucose, weight management and being physically active.

    Autonomic neuropathy affects blood flow, perspiration and skin hydration. This can lead to dry, cracking skin and calluses. It may also impair one’s ability to fight infection. Autonomic neuropathy can also affect other body systems:

    • Genitourinary: problems with bladder, erectile dysfunction.
    • Gastrointestinal: gastroparesis, diarrhea, constipation
    • Cardiovascular: orthostatic hypotension, silent heart attack
      Impaired insulin counter-regulation: hypoglycemia unawareness
    • Sudomotor: abnormal sweating
    • Pupillary: difficulty seeing in the dark.

    Nephropathy
    Diabetic nephropathy occurs in 20-40% of those with diabetes. Risk factors are listed below.

     
Non-modifiable risk factors Modifiable risk factors
Duration of diabetes
Family history of hypertension or
diabetic nephropathy
Race (higher in African American,
Hispanic and Native Americans)
Gender (men higher than women)
Hypertension
Hyperglycemia
Dyslipidemia
Smokin
g
     

A family history of high blood pressure and/or the presence of hypertension increase the risk to develop kidney disease and hypertension speeds the progress of kidney disease when it already exists.

Guidelines for reducing one’s risk of Kidney Disease

  Goal
Blood Pressure

Check at every medical visit
.. Optimal: < 120/80 mmHg
.. Minimal goal: < 130/80 mmHg
Take medications as prescribed

Cigarette Smoking

Advise not to smoke
Smoking cessation counseling for those who smoke

Diabetes

Strive for near normal blood glucose levels
Monitor blood glucose levels regularly
Take medications as prescribed

Diet

Avoid a high protein diet. Limiting protein to 0.8 g/kg if
any evidence of chronic kidney disease.
DASH Diet (See chapter 13 Hypertension and Diabetes)

Lipids

Check lipid profile at least once a year
.. LDL cholesterol < 100 mg/dl
.. HDL cholesterol > 40 mg/dl (men); > 50 mg/dl (women)
.. Triglycerides < 150 mg/dl
.. Non-HDL cholesterol* < 130
Take medications as prescribed

Lab Testing

Microalbumin: < 30 ug/mg
Type 1: within 5 years of diagnosis, then annually
Type 2: at diagnosis, then annually
Serum Creatinine and Calculated GFR*: annually

Weight management

BMI of 18.5-24.9
Waist circumference: < 35“ (women); < 40“ (men)

* For GFR calculator: go to www.nkdep.nih.gov/professionals/gfr_calculators/

Retinopathy
Diabetes is the leading cause of blindness in the US among those aged 20-74. Eye disease is 25 times more common among persons with diabetes than the general population. Listed below are common eye problems in persons with diabetes.

  Functional losses Treatment Prevention
Cataracts (clouding of the lens of the eye) Blurry vision
Reduced night vision
Problems with glare
Fading of colors
Surgery to replace the lens BG control
Annual eye exam
Glaucoma (group of eye diseases that damage the optic nerve) None in early stages
Loss of peripheral vision
Difficulty with night or low vision
Lower eye pressure (eye drops or surgery)
Annual eyeball pressure check
Retinopathy (microvascular disease of the retina) None in early stages
Later: blurry vision, floaters, flashing lights, sudden vision loss
Dependent on severity
Annual dilated eye exam
Strive for optimal blood
pressure, lipid and
glycemic control
Smoking cessation

Periodontal Disease
Periodontal disease is the most common oral complication of diabetes. It is more prevalent in those with poorly controlled diabetes. Prevention of periodontal disease involves striving for optimal glycemic control, good oral hygiene (regular brushing and flossing of teeth) and follow-up every 6 months with a dental professional.

Flu and Pneumonia
Influenza and pneumonia are common, preventable infectious diseases associated with high mortality and morbidity in those with chronic diseases. Vaccination guidelines are listed below.
Influenza: annual to all with diabetes 6 months of age.
Pneumonia: one lifetime vaccine for adults with diabetes. A one-time revaccination is recommended for those >65 years of age previously immunized when they were <65 years of age if the vaccine was administered >5 years ago.

References:
Franz MJ et al. (2003). A Core Curriculum for Diabetes Educators, 5th Ed., Diabetes Complications. American Association of Diabetes Educators, Chicago.

Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease
among adults with previously diagnosed diabetes. JAMA 291:335–342, 2004.

American Diabetes Association (2006). Clinical Practice Recommendations. Diabetes Care. Supplement. Vol 29.

   
Independent Study Modules
Email Us with Your Comments!
Clean Bill of Health